Sunayama, Tsutomu
Maeda, Daichi
Matsue, Yuya
Kagiyama, Nobuyuki
Jujo, Kentaro
Saito, Kazuya
Kamiya, Kentaro
Saito, Hiroshi
Ogasawara, Yuki
Maekawa, Emi
Konishi, Masaaki
Kitai, Takeshi
Iwata, Kentaro
Wada, Hiroshi
Hiki, Masaru
Dotare, Taishi
Kasai, Takatoshi
Nagamatsu, Hirofumi
Ozawa, Tetsuya
Izawa, Katsuya
Yamamoto, Shuhei
Aizawa, Naoki
Yonezawa, Ryusuke
Oka, Kazuhiro
Momomura, Shin-ichi
Minamino, Tohru
Funding for this research was provided by:
Japan Society for the Promotion of Science (18K15862)
Japan Heart Foundation Research Grant.
Novartis Pharma Research Grants
Article History
Received: 27 September 2021
Accepted: 4 February 2022
First Online: 18 February 2022
Competing interests
: Dr. Yuya Matsue and Takatoshi Kasai are affiliated with a department endowed by Philips Respironics, ResMed, Teijin Home Healthcare, and Fukuda Denshi; Dr. Yuya Matsue received an honorarium from Otsuka Pharmaceutical Co and Novartis Japan. Dr Nobuyuki Kagiyama reports grants from Philips, Asahi KASEI Corporation, Toho Holdings Co. Ltd, and Inter Reha Co. Ltd, that are not related to the content of this article. Dr. Kentaro Kamiya has received research funding from Eiken Chemical Co., Ltd. The other authors have nothing to declare.